Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.15B |
| 3 |
GE HealthCare
GEHC
|
+$552M |
| 4 |
Danaher
DHR
|
+$447M |
| 5 |
Strategy Inc
MSTR
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$989M |
| 2 |
Boeing
BA
|
+$893M |
| 3 |
Bank of America
BAC
|
+$753M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$750M |
| 5 |
Coca-Cola
KO
|
+$638M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.24% |
| 2 | Technology | 2.87% |
| 3 | Financials | 2.43% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13176
CALL
Cellectar Biosciences
CLRB
$24.6M
| $18.2K | ﹤0.01% |
1,927
+794
| +70% | +$7.19K |
|
13177
CALL
Anika Therapeutics
ANIK
$288M
| $18K | ﹤0.01% |
1,200
-600
| -33% | -$9.98K |
|
13178
PUT
Centuri Holdings
CTRI
$2.38B
| $18K | ﹤0.01% |
1,100
+500
| +83% | +$9.62K |
|
|
RTB
13179
RTB Digital
RTB
$237M
| $18K | ﹤0.01% |
+520
| New | +$20.9K |
|
|
FLYE
13180
Fly-E Group
FLYE
$2.81M
| $18K | ﹤0.01% |
+413
| New | +$21.2K |
|
13181
CALL
Janus International
JBI
$697M
| $18K | ﹤0.01% |
2,500
-700
| -22% | -$5.56K |
|
|
LSEA
13182
PUT
DELISTED
Landsea Homes
LSEA
| $18K | ﹤0.01% |
2,800
-5,200
| -65% | -$40.3K |
|
13183
PUT
Thryv Holdings
THRY
$96M
| $17.9K | ﹤0.01% |
1,400
+400
| +40% | +$6.63K |
|
|
NB
13184
PUT
NioCorp Developments
NB
$744M
| $17.9K | ﹤0.01% |
9,100
+5,600
| +160% | +$11.3K |
|
13185
Healthcare Triangle
HCTI
$2.45M
| $17.8K | ﹤0.01% |
+4
| New | +$37K |
|
13186
CALL
Cerus
CERS
$601M
| $17.8K | ﹤0.01% |
12,800
-35,800
| -74% | -$59.9K |
|
13187
CALL
Matthews International
MATW
$725M
| $17.8K | ﹤0.01% |
800
+200
| +33% | +$5.2K |
|
|
NAKA
13188
Nakamoto Inc
NAKA
$88.2M
| $17.8K | ﹤0.01% |
+276
| New | +$18.6K |
|
13189
Lantronix
LTRX
$289M
| $17.7K | ﹤0.01% |
7,117
-91,318
| -93% | -$294K |
|
13190
PUT
Enliven Therapeutics
ELVN
$4.31B
| $17.7K | ﹤0.01% |
900
+600
| +200% | +$12.9K |
|
13191
PUT
Procure Space ETF
UFO
$634M
| $17.7K | ﹤0.01% |
800
+300
| +60% | +$7.14K |
|
|
GDXY
13192
CALL
YieldMax Gold Miners Option Income Strategy ETF
GDXY
$237M
| $17.7K | ﹤0.01% |
1,100
-1,800
| -62% | -$27.8K |
|
|
DSL
13193
CALL
DoubleLine Income Solutions Fund
DSL
$1.24B
| $17.7K | ﹤0.01% |
1,400
-2,900
| -67% | -$36.7K |
|
13194
CALL
DHI Group
DHX
$171M
| $17.7K | ﹤0.01% |
12,700
-14,600
| -53% | -$33.1K |
|
13195
CALL
Suzano
SUZ
$9.99B
| $17.7K | ﹤0.01% |
1,900
-9,900
| -84% | -$99K |
|
13196
PUT
BlackRock TCP Capital
TCPC
$342M
| $17.6K | ﹤0.01% |
2,200
-20,200
| -90% | -$175K |
|
|
NOTE
13197
PUT
DELISTED
FiscalNote
NOTE
| $17.6K | ﹤0.01% |
1,817
+909
| +100% | +$13.7K |
|
13198
CALL
Dyadic International
DYAI
$28.2M
| $17.6K | ﹤0.01% |
+13,000
| New | +$19.6K |
|
13199
CALL
Pulmonx
LUNG
$104M
| $17.5K | ﹤0.01% |
2,600
+2,100
| +420% | +$14.9K |
|
13200
CALL
Bowman Consulting
BWMN
$733M
| $17.5K | ﹤0.01% |
+800
| New | +$18.6K |
|
Similar funds
Ken Griffin's Q1 2025 Portfolio in Review
As of Q1 2025, Ken Griffin held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,709 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.
By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
- Ken Griffin added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
- Ken Griffin's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
- Ken Griffin fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
- Ken Griffin's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
- Ken Griffin opened 1,671 new positions and closed 1,709 in Q1 2025.
- Ken Griffin's portfolio value fell 8.7% quarter-over-quarter to $527B.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.